These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 33128625)

  • 41. Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration.
    Kupie TC; Trusley C; Ben M; Trissel LA
    Am J Health Syst Pharm; 2008 Sep; 65(18):1735-59. PubMed ID: 18769000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Utility of a Compatibility Chart for Continuous Infusions in the Intensive Care Unit.
    Kondo M; Tanaka C; Tagami T; Nagano M; Sugaya K; Tagui N; Kaneko J; Kudo S; Kuno M; Unemoto K; Takase H
    J Nippon Med Sch; 2022; 89(2):227-232. PubMed ID: 35545550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physical compatibility of colistin with analgesics during simulated Y-site administration.
    Dettlaff K; Kowalska A; Gostyńska A
    Am J Health Syst Pharm; 2024 Jun; 81(13):e365-e371. PubMed ID: 38358317
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incompatibility of the short-acting benzodiazepine remimazolam with common perioperative medication.
    Hofmann P; Bachmann L; Brümmer P; Drexler B
    BMC Anesthesiol; 2024 Jul; 24(1):233. PubMed ID: 38992570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma-Lyte 148 and Plasma-Lyte 148 + 5% glucose compatibility with commonly used critical care drugs.
    Hammond S; Wignell A; Cooling P; Barrett DA; Davies P
    Intensive Care Med Exp; 2020 Jun; 8(1):25. PubMed ID: 32577941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Feb; 51(4):495-9. PubMed ID: 8017415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physical and chemical compatibility of daptomycin with nine medications.
    Lai JJ; Brodeur SK
    Ann Pharmacother; 2004 Oct; 38(10):1612-6. PubMed ID: 15328397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploring a case of incompatibility in a complex regimen containing Plasma-Lyte 148 in the pediatric intensive care.
    Nilsson N; Nguyen V; Nezvalova-Henriksen K; Tho I
    Paediatr Anaesth; 2023 Mar; 33(3):211-218. PubMed ID: 36336980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
    Asempa TE; Avery LM; Kidd JM; Kuti JL; Nicolau DP
    Am J Health Syst Pharm; 2018 Jul; 75(14):1048-1056. PubMed ID: 29895521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration.
    So W; Kim L; Thabit AK; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2017 Jan; 74(1):e55-e63. PubMed ID: 28007722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Compatibility of drug infusions in the NICU.
    Kalikstad B; Skjerdal A; Hansen TW
    Arch Dis Child; 2010 Sep; 95(9):745-8. PubMed ID: 20570841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1993 Nov; 50(11):2359-63. PubMed ID: 8266963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic review of physical and chemical compatibility of commonly used medications administered by continuous infusion in intensive care units.
    Kanji S; Lam J; Johanson C; Singh A; Goddard R; Fairbairn J; Lloyd T; Monsour D; Kakal J
    Crit Care Med; 2010 Sep; 38(9):1890-8. PubMed ID: 20562698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration.
    Katip W
    Am J Health Syst Pharm; 2017 Jul; 74(14):1099-1102. PubMed ID: 28687555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
    Karnatz NN; Wong J; Kesler H; Baaske DM; Speicher ER
    Am J Hosp Pharm; 1988 Feb; 45(2):368-71. PubMed ID: 2896460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents.
    Staven V; Iqbal H; Wang S; Grønlie I; Tho I
    J Pharm Pharmacol; 2017 Apr; 69(4):448-462. PubMed ID: 27714809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site Administration.
    Kidd JM; Avery LM; Asempa TE; Nicolau DP; Kuti JL
    Clin Ther; 2018 Feb; 40(2):261-269. PubMed ID: 29290374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physicochemical Compatibility of Dexmedetomidine With Parenteral Nutrition.
    Campos-Baeta Y; Saavedra-Mitjans M; Garin N; Cardenete J; Cardona D; Riera P
    Nutr Clin Pract; 2020 Oct; 35(5):967-972. PubMed ID: 31482649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Compatibility of filgrastim with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Aug; 51(15):1907-13. PubMed ID: 7524319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Compatibility of pentoxifylline and parenteral medications.
    Campbell AL; Petrovski M; Senarathna SG; Mukadam N; Strunk T; Batty KT
    Arch Dis Child; 2020 Apr; 105(4):395-397. PubMed ID: 31871042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.